Jay S Skyler MD
Diabetes, Lipid Metabolism
Professor of Medicine, University Miami School of Medicine
Join to View Full Profile
1450 Nw 10th AveMiami, FL 33136
Phone+1 305-243-3636
Fax+1 305-243-6575
Dr. Skyler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalResidency, Internal Medicine, 1970 - 1973- Duke University HospitalInternship, Transitional Year, 1969 - 1970
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1969
Certifications & Licensure
FL State Medical License 1976 - 2027
NC State Medical License 1972 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1) Start of enrollment: 1994 Feb 01
- TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
- New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial Start of enrollment: 2004 May 01
- Join now to see all
Publications & Presentations
PubMed
- Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [lett...Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino
Diabetologia. 2025-04-01 - Two DRB3 residues predictively associate with the progression to type 1 diabetes among DR3 carriers.Lue Ping Zhao, George K Papadopoulos, Jay S Skyler, William W Kwok, George P Bondinas
JCI Insight. 2025-03-04 - A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts.Jay M Sosenko, David Cuthbertson, Laura M Jacobsen, Maria J Redondo, Emily K Sims
Diabetes Technology & Therapeutics. 2025-03-01
Press Mentions
How a Pioneering Diabetes Drug Offers Hope for Preventing Autoimmune DisordersFebruary 15th, 2023- The Diabetes Research Institute Appoints World-Renowned Diabetes Expert, Matthias Von Herrath, M.D., to Scientific DirectorJanuary 26th, 2023
- Researchers to Report First Results from Highly Anticipated Type 1 Diabetes Intervention TrialMay 26th, 2022
- Join now to see all
Grant Support
- Type 1 Diabetes Trialnet: Support FacilitiesNational Institute Of Diabetes And Digestive And Kidney Diseases2007
- Type 1 Diabetes TrialnetNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
- Diabetes Prevention Trial-Iddm (Dpt-1)National Institute Of Diabetes And Digestive And Kidney Diseases1994–2000
- Insulin Sensitivity, Blood Pressure, And Glucose ToleranceNational Heart, Lung, And Blood Institute1991–1995
- Diabetes Prevention TrialNational Institute Of Diabetes And Digestive And Kidney Diseases1994
- Prevention Of Type I Diabetes MellitusNational Institute Of Diabetes And Digestive And Kidney Diseases1993
- Diabetes Mellitus: Pathogenesis And Immune InterventionNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1987
- Diabetes Mellitus: Pathogenesis And Immune InterventionNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
